CFSAN
This article was originally published in The Tan Sheet
Executive Summary
Ephedra strategy, dietary supplement labeling guide and research plan made "B" list priorities for 2001, foods center says in mid-year accomplishments paper issued July 10. Actions are not expected to be completed by end of FY 2001, as originally proposed (1"The Tan Sheet" Jan. 15, p. 3). Urgent matters such as BSE, food allergens, genetically modified corn forced CFSAN to reframe priorities for fiscal year, center explains
You may also be interested in...
GMPs, Food Safety, Industry Guidances Among CFSAN’s 2002 Top Priorities
Industry guidances on dietary supplement regulations and labeling issues are slated to be released by FDA's Center for Food Safety & Applied Nutrition over the next two years
CFSAN Congressional Reports On DSHEA, Pearson, Strategic Plan Slated
The Center for Food Safety & Applied Nutrition will submit reports to Congress this fiscal year on the cost of addressing various dietary supplement issues.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC